These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 5524840)

  • 1. [Change in antiplasmin activity in patients with neoplasms of the urinary bladder].
    Zavadich IB; Kotovshchikova MA; Fedorova ZD
    Urol Nefrol (Mosk); 1970; 35(1):45-7. PubMed ID: 5524840
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical investigation on the effect of intravesical instillation of antifibrinolytic agents with bacillus Calmette-Guerin on preventing bladder cancer recurrence].
    Ding GQ; Shen ZJ; Lu J; Jin XD; Chen J; Shi SF
    Zhonghua Wai Ke Za Zhi; 2005 Nov; 43(22):1457-60. PubMed ID: 16318813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Activity of aminopeptidase in blood and urine in patients with bladder neoplasms].
    Otreba L
    Pol Tyg Lek; 1969 Sep; 24(38):1440-2. PubMed ID: 5349483
    [No Abstract]   [Full Text] [Related]  

  • 4. [The activity of protein C in the blood of patients with bladder carcinoma].
    Iwan-Zietek I; Zietek Z; Kotschy M; Wolski Z; Chodakowska-Akolińska G
    Pol Merkur Lekarski; 1997 Jan; 2(9):193-5. PubMed ID: 10907026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of diagnostic and prognostic values of urinary interleukin-8, tumor necrosis factor-alpha, and leukocyte arylsulfatase-A activity in patients with bladder cancer.
    Koçak H; Oner-Iyidoğan Y; Koçak T; Oner P
    Clin Biochem; 2004 Aug; 37(8):673-8. PubMed ID: 15302609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional activities and concentrations of plasmin inhibitors in normal subjects and D.I.C. patients.
    Velasco F; Torres A; Andres P; Duran MI
    Thromb Haemost; 1982 Jun; 47(3):275-7. PubMed ID: 6180498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Activity of antithrombin III in the blood of patients with bladder cancer].
    Zietek Z; Iwan-Zietek I; Kotschy M; Wiśniewska E; Tyloch F
    Pol Merkur Lekarski; 1997 Apr; 2(10):268-9. PubMed ID: 9377663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antifibrinolytic activity of the blood in patients with disorders of the coronary circulation].
    Panchenko VM; Pastorova VE
    Ter Arkh; 1966 Dec; 38(12):21-4. PubMed ID: 6003263
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the determination of antifibrinolysin (antiplasmin) activity in the blood].
    Kotovshchikova MA; Pleshakov VT
    Lab Delo; 1968; 12():715-7. PubMed ID: 4185066
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of intravesical instillation of antifibrinolytic agents on bacillus Calmette-Guerin treatment of superficial bladder cancer: a pilot study.
    Pan CW; Shen ZJ; Ding GQ
    J Urol; 2008 Apr; 179(4):1307-11; discussion 1311-2. PubMed ID: 18289576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low dose heparin in elective abdominal surgery. Correlation between concentrations of heparin, antithrombin III and antiplasmin in patients with and without DVT.
    Kruse-Blinkenberg HO; Gormsen J; Jensen J; Thomsen F; Wille-Jørgensen P
    Acta Chir Scand; 1980; 146(6):383-90. PubMed ID: 7008476
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the use of antifibrinolytic agents in urology].
    Rosdy E; Biró J; Szendröi Z; Szabó V
    Acta Chir Acad Sci Hung; 1969; 10(1):25-35. PubMed ID: 5800598
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum interleukin-18 and nitric oxide activity in bladder carcinoma.
    Bukan N; Sözen S; Coskun U; Sancak B; Günel N; Bozkirli I; Senocak C
    Eur Cytokine Netw; 2003; 14(3):163-7. PubMed ID: 14656691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Estimation of serum beta 2 microglobulin in carcinoma of the bladder (author's transl)].
    Dimopoulos C; Fertakis A; Stathopoulos C; Goulandris N; Kastriotis J; Antipas A; Melissinos K
    J Urol (Paris); 1982; 88(1):11-3. PubMed ID: 6174647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The physiology of fibrinolysis. II. Antiplasmin.
    Thornes RD; O'Donnell JM; O'Brien DJ
    Ir J Med Sci; 1967 Feb; 6(494):73-81. PubMed ID: 6040790
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes in the blood coagulation processes in patients irradiated with gamma rays of Co60].
    Paleani Vettori G; Monosi A; Trinci M
    Nunt Radiol; 1966 Oct; 32(10):983-94. PubMed ID: 5997171
    [No Abstract]   [Full Text] [Related]  

  • 17. [The significance of local fibrinolysis increase in symptomatic hematuria and its inhibition by p-aminomethylbenzoic acid].
    Hellinger J
    Z Urol Nephrol; 1966 Sep; 59(9):633-9. PubMed ID: 5997446
    [No Abstract]   [Full Text] [Related]  

  • 18. Relationship of blood groups and transitional cell carcinoma of the bladder.
    Kirkali Z; Eryigit M
    Int Urol Nephrol; 1993; 25(3):255-7. PubMed ID: 8225826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Urinary-plasmin alpha 2 plasmin inhibitor complex (PIC) in patients with diabetic nephropathy].
    Saigo K; Ryo R; Yamaguchi N
    Rinsho Byori; 1993 Jul; 41(7):785-8. PubMed ID: 8361049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dynamics of the titers of antifibrinolysin, antistreptolysin-O, hyaluronidase activity and allergic reaction of the skin in patients with rheumatism].
    Angulova AD
    Vopr Revm; 1966; 6(1):30-8. PubMed ID: 5986392
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.